Skip to content Skip to left sidebar Skip to footer

J&J COVID-19 Vaccine Pause Lifted by FDA

J&J COVID-19 Vaccine Pause Lifted by FDA

Attention COVID-19 Vaccine Providers:

On Friday April 23, the CDC and FDA lifted the pause in the use of Johnson & Johnson’s Janssen COVID-19 vaccine after completing a review of reports of adverse events. Today, the following operational guidance will allow for the return of J&J vaccine to distribution and administration. The J&J/Janssen vaccine may be administered now.

Health care providers administering the vaccine and vaccine recipients or caregivers should review the following documents:

Both documents have been revised to include information about the risk of this syndrome that has occurred in a very small number of people who have received the Janssen COVID-19 Vaccine.

Please refer to these additional resources for more information:

Thank you for keeping Philadelphia safe and healthy from COVID-19. If you have any questions, please email